Your support drives research nationally
Crohn’s and Colitis Canada is able to fund these important research activities and more, thanks to your support.
LEGEND
GIA - Grants-in-Aid of Research: These are investigator driven research that fall under 4 domains: finding causes and triggers,
INN - The Innovation in IBD grant aims to finance creative and original methods for conducting research on inflammatory bowel disease (IBD). It is designed to encourage and facilitate research that may not fit into the conventional framework of medical research.
PACE - The Promoting Access and Care through Centres of Excellence (PACE) network brings together leading inflammatory bowel disease centres from across the country to improve health outcomes, address gaps in care, and develop solutions that can create changes in the public healthcare system.
The New Frontiers Award - A cutting-edge initiative that seeks to empower researchers to explore novel and innovative approaches to tackling inflammatory bowel disease (IBD).
GEM - The Genetic, Environmental, Microbial (GEM) Project is a global research study that looks to uncover possible triggers of Crohn’s disease.
CIRC - The Canadian Inflammatory Bowel Disease Research Consortium is a network of clinician scientists working together to promote and conduct clinical research in inflammatory bowel diseases through collaboration of multiple Canadian centres.
CANIBD - A Community of Practice for nurses working across Canada in the field of inflammatory bowel disease (IBD) with a vision of improving the quality of care of people living with IBD.
Early Career Researchers
Table of Funded Research
| Program |
Study Title |
Funding Start year |
Amount Funded in 2022 |
| IIN |
Understanding how proteins protect the gut from harmful bacteri |
2022 |
$44,239 |
| IIN |
Investigating immune mechanisms underlying ulcerative colitis in the elderly |
2022 |
$49,828 |
| IIN |
Unravelling the link between Crohn’s disease and Type-2 diabetes |
2022 |
$50,000 |
| GIA |
Understanding the causes of ulcerative colitis using a new lab model |
2022 |
$62,500 |
| GIA |
Understanding inflammatory arthritis among people living with IBD |
2022 |
$46,490 |
| GIA |
Understanding how microbes and viruses affect colitis |
2022 |
$62,500 |
| GIA |
Function of follicular dendritic cell secreted protein in ulcerative colitis |
2022 |
$62,470 |
| GIA |
Unravelling the link between Crohn’s disease and Type-2 diabetes |
2022 |
$62,500 |
| GIA |
Understanding how E.Coli infects the lining of the colon among colitis patients |
2022 |
$62,500 |
| GIA |
Understanding how proteins protect the gut from harmful bacteria |
2022 |
$62,500 |
| GIA |
Deciphering the role of the gut microbiota in the development of Crohn’s disease |
2022 |
$62,450 |
| GIA |
The role of microbial metabolism in food intolerances associated with inflammatory bowel disease |
2021 |
$62,500 |
| GIA |
Ascertaining population-based long-term outcomes in infl ammatory bowel disease patients with primary sclerosing cholangitis |
2021 |
$31,250 |
| GIA |
Defining time-trends, regional variations, and impact of health-care utilization on pregnancy outcomes in women with inflammatory bowel disease |
2021 |
$43,309 |
| GIA |
Novel P2Y6 antagonists as a potential therapy for infl ammatory bowel disease |
2021 |
$125,000 |
| GIA |
The use of SGLT2 inhibitors in the treatment of infl ammatory bowel disease |
2021 |
$62,500 |
| GIA |
Role of the gut mucin sialome in protection from microbiota-driven colitis |
2021 |
$62,500 |
| GIA |
Using intestinal organoids to model chronic injury and repair in IBD |
2021 |
$31,250 |
Learn how IBD Champion, Peter Dobranowski is paying forward the support he's received from the IBD community and Crohn's and Colitis Canada >